Michel Maira

2.4k total citations · 1 hit paper
12 papers, 837 citations indexed

About

Michel Maira is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michel Maira has authored 12 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Michel Maira's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Advanced Breast Cancer Therapies (2 papers). Michel Maira is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Lung Cancer Treatments and Mutations (4 papers) and Advanced Breast Cancer Therapies (2 papers). Michel Maira collaborates with scholars based in Switzerland, United States and United Kingdom. Michel Maira's co-authors include Carlos Garcı́a-Echeverrı́a, Josep Lluís Parra, Serena Di Cosimo, Ben Markman, Joaquı́n Arribas, Maurizio Scaltriti, Pieter J.A. Eichhorn, Violeta Serra, Marta Guzmán and José Baselga and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Michel Maira

12 papers receiving 822 citations

Hit Papers

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Sig... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
    2008 626 citations Violeta Serra, Ben Markman et al. Cancer Research profile →

Peers

Michel Maira
Josep Lluís Parra United Kingdom
Leila R. Martins Portugal
J. Rafael Sierra United States
K. Papadopoulos United States
Ivy Fearen United States
Hiroshi Sootome Japan
Sauveur-Michel Maira Switzerland
Elisabeth Llonch Switzerland
Lisa Malburg United States
François Ringeisen France
Josep Lluís Parra United Kingdom
Michel Maira
Citations per year, relative to Michel Maira Michel Maira (= 1×) peers Josep Lluís Parra

Countries citing papers authored by Michel Maira

Since Specialization
Citations

This map shows the geographic impact of Michel Maira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Maira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Maira more than expected).

Fields of papers citing papers by Michel Maira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Maira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Maira. The network helps show where Michel Maira may publish in the future.

Co-authorship network of co-authors of Michel Maira

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Maira. A scholar is included among the top collaborators of Michel Maira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Maira. Michel Maira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Clarke, Paul A., Karen Barker, Yvan H. Chanthery, et al.. (2016). Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors. Oncotarget. 7(36). 57525–57544. 40 indexed citations
2.
Maira, Michel, Christian Schnell, Pier‐Luigi Lollini, et al.. (2012). Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain. Annals of Oncology. 23. ix537–ix537. 13 indexed citations
3.
Elfiky, Aymen, Saadia A. Aziz, Patricia J. Conrad, et al.. (2011). Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer. Journal of Translational Medicine. 9(1). 133–133. 41 indexed citations
4.
Voliva, Charles F., Sabina Pecchi, Matthew T. Burger, et al.. (2010). Abstract 4498: Biological characterization of NVP-BKM120, a novel inhibitor of phosphoinosotide 3-kinase in Phase I/II clinical trials. Cancer Research. 70(8_Supplement). 4498–4498. 29 indexed citations
5.
Maira, Michel, Daniel L. Menezes, Sabina Pecchi, et al.. (2010). Abstract 4497: NVP-BKM120, a novel inhibitor of phosphoinosotide 3-kinase in Phase I/II clinical trials, shows significant antitumor activity in xenograft and primary tumor models. Cancer Research. 70(8_Supplement). 4497–4497. 13 indexed citations
6.
Carretero, Julián, Takeshi Shimamura, Klarisa Rikova, et al.. (2009). Abstract B103: Integrative genomic and proteomic analyses identify novel targets for Lkb1 deficient metastatic lung tumors. Molecular Cancer Therapeutics. 8(12_Supplement). B103–B103. 4 indexed citations
7.
Serra, Violeta, Ben Markman, Maurizio Scaltriti, et al.. (2008). NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations. Cancer Research. 68(19). 8022–8030. 626 indexed citations breakdown →
8.
9.
O’Reilly, Terence, Markus Wartmann, Joseph Brueggen, et al.. (2008). Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 62(6). 1045–1054. 60 indexed citations
10.
Stauffer, Frédéric, Carlos Garcı́a-Echeverrı́a, Pascal Furet, et al.. (2007). Medicinal chemistry efforts towards the identification and development of inhibitors of phosphatidylinositol 3-kinases (PI3Ks) and related protein kinases for cancer treatment. Cancer Research. 67. 3953–3953. 2 indexed citations
11.
Maira, Michel. (2007). Biochemical, cellular and in vivo profiling of a new PI3K inhibitor from the imidazoquinoline series. Cancer Research. 67. 7 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep Lluís Parra Breakdown of academic impact, for papers by Leila R. Martins Breakdown of academic impact, for papers by J. Rafael Sierra Breakdown of academic impact, for papers by K. Papadopoulos Breakdown of academic impact, for papers by Ivy Fearen Breakdown of academic impact, for papers by Hiroshi Sootome Breakdown of academic impact, for papers by Sauveur-Michel Maira Breakdown of academic impact, for papers by Elisabeth Llonch Breakdown of academic impact, for papers by Lisa Malburg Breakdown of academic impact, for papers by François Ringeisen
Rankless by CCL
2026